Update on the COVID-19 pandemic

Information regarding COVID-19 is in constant change, as is the situation regarding vaccination and prioritization for immune-compromised individuals.

If you have any COVID-19-related questions, we’ve created a specific COVID section on our website that can be accessed by clicking here or by selecting the “News & Events” tab from our homepage. In this section, you’ll find the latest news and information about the pandemic in Canada from trustworthy and reliable sources.

Any specific questions that you may have regarding the COVID-19 vaccination, delays between vaccine dosing, and prioritization within your province are best answered by your healthcare team. They’re the ones who know you and your particular situation and are therefore in a position to best address your unique concerns.

Created by, and entirely focused on, Canadians impacted by myeloma, Myeloma Canada is the only national charitable organization committed to providing you with the most up-to-date and reliable information on myeloma. Some of the ways we do this is through our monthly e-newsletter, “Myeloma Matters”, as well as through our social media platforms.

Please don’t hesitate to contact us at contact@myeloma.ca or toll-free at 1-888-798-5771 with any questions regarding our programs and services.

Close

Make a donation

Scientific Advisory Board

The mission of the Myeloma Canada Research Network is to conduct clinical and translational research in a collaborative manner to improve patient outcomes in multiple myeloma, and to provide scienti cally valid and peer-reviewed consensus opinions on the diagnosis and treatment of multiple myeloma.

Myeloma Canada's Scientic Advisory Board

Nizar J Bahlis, MD
Tom Baker Cancer Center
Assistant Professor
University of Calgary
Foothills Medical Center
Calgary, AB

Andrew R Belch, MD
Division of Medical Oncology
Department of Oncology
Cross Cancer Institute
University of Alberta
Edmonton, AB

Christine Chen, MD
Assistant Professor
Department of Medical
Oncology and Hematology
Princess Margaret Hospital
University Health Network
Toronto, ON

Jonathan Keats, PhD
Assistant Professor
Integrated Cancer Genomics Division
Translational Genomics
Research Institute
Phoenix, AZ

Richard LeBlanc, MD
Maisonneuve-Rosemont Hospital
Clinical Assistant Professor of Medicine
University of Montreal
Montreal, QC

Paola Neri, MD, PhD
Clinical Assistant Professor
University of Calgary
Calgary, AB

Linda Pilarski, PhD
Division of Experimental Oncology
Department of Oncology
Cross Cancer Institute
University of Alberta
Edmonton, AB
Member, IMF Scientific Advisory Board

Donna E Reece, MD
Professor of Medicine
Director, Program for Multiple Myeloma and Related Diseases
Department of Medical
Oncology and Hematology
Princess Margaret Hospital
University Health Network
Toronto, ON
Member, IMF Scientific Advisory Board

Tony Reiman, MD
Medical Oncologist
Saint John Regional Hospital
Assistant Dean of Research Dalhousie Medicine
New Brunswick
Saint John, NB

Jean Roy, MD
Maisonneuve-Rosemont Hospital
University of Montreal
Montreal, QC

Michael Sebag, MD, PhD
Assistant Professor
McGill University Faculty of Medicine
McGill University Health Centre
Montreal, QC

Chaim Shustik, MD
Professor of Medicine & Oncology
McGill University Faculty of Medicine
Royal Victoria Hospital
Montreal, QC
Member, IMF Scientific Advisory Board

Kevin J Song, MD
BC Cancer Research Centre
Vancouver General Hospital
Vancouver, BC

Rodger Tiedemann, PhD, ChB, MB
Scientist, Ontario Cancer Institute
Staff Hematologist
Division of Medical Oncology & Hematology
Princess Margaret Hospital
Assistant Professor of Medicine
University of Toronto
Toronto, ON

Suzanne Trudel, MD
Associate Professor
Clinician/Research Scientist
Department of Medical Oncology and Hematology
Princess Margaret Hospital
University Health Network
Toronto, ON

Darrell White, MD
Nova Scotia Cancer Centre
Queen Elizabeth II Health
Services Centre
Dalhousie University
Halifax, NS